Ray Parker, MD
Dermatology · Benton, ARNPI 1558356360
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 293 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,366, 2.5 times the $541 reported in 2019.
Across 293 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- AbbVie$957
- Lilly USA, LLC$813
- Johnson & Johnson$403
- Sun Pharmaceutical Industries Inc.$398
- Regeneron Healthcare Solutions, Inc.$342
- plus $1K from 19 others
What the payments were for
- Food & beverage$5,31198%
- Education$902%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 54 | $1,097 |
| AbbVie | 62 | $957 |
| Lilly USA, LLC | 46 | $813 |
| Johnson & Johnson | 21 | $403 |
| Sun Pharmaceutical Industries Inc. | 21 | $398 |
| Regeneron Healthcare Solutions, Inc. | 16 | $342 |
| LEO Pharma Inc. | 14 | $324 |
| E.r. Squibb & Sons, L.L.C. | 14 | $234 |
| UCB, Inc. | 10 | $206 |
| Incyte Corporation | 7 | $134 |
| Sanofi | 5 | $100 |
| Pfizer | 6 | $91 |
| Amgen | 3 | $61 |
| Bristol Myers Squibb | 2 | $33 |
| Genentech USA, Inc. | 2 | $27 |
| Kerecis Limited | 1 | $26 |
| Krystal Biotech Inc | 1 | $24 |
| Dermavant Sciences, Inc. | 1 | $20 |
| Organon | 1 | $20 |
| Sensus Healthcare, Inc. | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $16 |
| Fresenius Kabi USA, LLC | 1 | $15 |
| Elekta, Inc. | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $14 |
| Arcutis Biotherapeutics, Inc. | 1 | $13 |
How this compares
$5,401 in reported general payments places this provider in the 65th percentile of 75 dermatology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 21 | $155,300 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 14 | $119,769 |
| Triamcinolone Acetonide | 785 | $6,376 |
| Minocycline Hcl | 313 | $5,971 |
| Fluocinonide | 126 | $5,131 |
| Clobetasol Propionate | 104 | $4,516 |
| Ketoconazole | 246 | $4,471 |
| Doxycycline Hyclate | 114 | $2,991 |
| MethotrexateMethotrexate Sodium | 100 | $2,637 |
| Fluorouracil | 21 | $1,568 |
| Metronidazole | 21 | $1,373 |
| Hydrocortisone | 260 | $1,164 |
| Prednisone | 188 | $940 |
| ValacyclovirValacyclovir Hcl | 36 | $849 |
| Mupirocin | 114 | $831 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Benton
- James GrahamBenton$8K
- Sandra JohnsonFort Smith$543K
- Scott JacksonFayetteville$533K
- Mildred CliftonBentonville$92K
- Lance HenryFayetteville$39K
- Jennifer JacksPine Bluff$21K
- Zachary NahmiasJonesboro$15K
- Phillip StitesFort Smith$15K
- Brian WayneLittle Rock$13K
- Andrea MabryLittle Rock$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.